Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (51 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Nov 2022 – 20 Aug 2026, limited by HSBC ELSS Tax saver Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | HSBC ELSS Tax saver Fund | Nifty 500 |
|---|---|---|
| 28 Nov 2022 | ₹100.00 | ₹100.00 |
| 21 Mar 2023 | ₹94.37 | ₹91.30 |
| 13 Jul 2023 | ₹109.49 | ₹105.32 |
| 03 Nov 2023 | ₹112.35 | ₹107.71 |
| 25 Feb 2024 | ₹134.02 | ₹128.69 |
| 17 Jun 2024 | ₹157.92 | ₹140.74 |
| 09 Oct 2024 | ₹171.21 | ₹149.51 |
| 30 Jan 2025 | ₹154.34 | ₹134.93 |
| 23 May 2025 | ₹163.92 | ₹144.33 |
| 14 Sep 2025 | ₹170.47 | ₹146.92 |
| 05 Jan 2026 | ₹174.25 | ₹152.42 |
| 29 Apr 2026 | ₹169.54 | ₹144.90 |
| 20 Aug 2026 | ₹182.73 | ₹148.96 |
| Metric | HSBC · Direct NAV ₹158.64 Very High risk ★★★★☆ | Category median ELSS · 51 funds |
|---|---|---|
| +8.32% | +3.05% | |
| +18.51% | +14.46% | |
| — | +13.60% | |
| — | +13.74% | |
| +17.56% | +14.97% | |
| +15.07% | — | |
| +18.94% | +16.84% | |
| — | +17.15% | |
| — | +15.41% | |
| Risk | ||
| 16.60% | 14.19% | |
| 0.72 | 0.52 | |
| 0.99 | 0.70 | |
| -19.21% | -35.94% | |
| Nifty 500 | — | |
| +5.45% | +1.57% | |
| 1.02 | 0.97 | |
| 118.4% | 102.3% | |
| 95.0% | 93.6% | |
| 1.20% | 1.06% | |
| ₹3,957Cr | ₹765.87Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 13% | 34% | |
| Abhishek Gupta | — | |
| 28 Nov 2022 | — | |
| 77 | — | |
| 28.6% | — | |
| 2.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.